Director Scientific Communications
enGene
·Yesterday
- Salary
- $220k – $238k/yr
- Location
- Boston, MA
- Workplace
- Hybrid
- Type
- Full-time
- Department
- Medical Affairs
- Seniority
- Director
- Education
- PhD
- Source
- Lever
Description
OPENING
enGene (NASDAQ: ENGN) is a late-stage biotechnology company, mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit enGene.com.
ROLE
We are seeking a dynamic and experienced Director/Senior Director to lead the areas of medical communications strategy, scientific communications and publications, and medical affairs operations. This includes oversight of scientific publications and building out the medical information function.
This individual will be responsible for ensuring alignment with company objectives, supporting the pre-launch and launch activities. You will work closely with Medical Affairs, Clinical Program Teams, & Corporate Communications.